Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality

Hospital Galdakao-Usansolo

Status: Completed

Conditions: Multimorbidity

Treatments: Other: annual follow up

Study type: Observational

Funder types: Other

Identifiers

NCT05574790

PI18/01438

Details and patient eligibility

About

A prospective qualitative quantitative study was designed to create predictive models of readmission in multimorbid patients.

Full description

Social determinants have been shown to be related to the probability of readmission and death in multimorbid patients. These are increasingly older, which makes them more likely to be readmitted when their preferences are usually to be at home. Objective: To create and validate prediction models for readmission and mortality during home transitional period (1 month) and up to a year, in multimorbid patients, including variables related to the patient and their social environment. Design: Quali-quantitative. 4 hospitals from 3 regions (Andalucia, Catalonia and the Basque Country) will participate . Patients presenting at least 2 of the Ollero's categories will be included. Variables will be identified by means of nominal groups of professionals and focal groups with patients and caregivers. These variables will be included in the final models join to clinical variables, PROMS (health related quality of life, burden of the caregiver , social support). Logistic/ Cox regression models will be developed and validated internally to identify the risk of readmission and death which will be validated in an external cohort. Expected results: We hope to provide the health system with stratification tools for polypathological patients that help in identifying those patients with the greatest need for individualized interventions.

Enrollment: 500 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients over 18 years of age
• Patients discharged from the Internal Medicine departments of the participating centers due to acute pathology, de novo or decompensation of a chronic pathology who also present at least 2 of the cathegories of Ollero et al.

Exclusion criteria

• Patients admitted for end-of-life treatment, scheduled admissions, exacerbation of rheumatic pathology or systemic disease, study of anaemia in patients with no-known comorbidity, search for neoplasia and acute processes without associated comorbidity. -
• Failure to sign the informed consent form.

Trial design

500 participants in 1 patient group

Admitted

Description:

We will include patients who had been admitted by meeting Ollero et al categories in hospitalization ward

Treatment:

Other: annual follow up